MAR 25, 2015 8:08 AM PDT

Legalizing Marijuana and the New Science of Weed

WRITTEN BY: Judy O'Rourke
More than a year into Colorado's experiment legalizing marijuana, labs testing the plants are able for the first time to take stock of the drug's potency and contaminants -- and openly paint a picture of what's in today's weed.

At the National Meeting & Exposition of the American Chemical Society (ACS), one such lab is presenting trends -- and some surprises -- that its preliminary testing has revealed about the marijuana now on the market.
Marijuana buds are often two to three times as potent as they were 30 years ago.
Three major patterns have emerged over the past few months since Andy LaFrate, PhD, and his lab began testing marijuana samples. Those patterns concern potency, amounts of a substance called CBD, and contaminants in the products.

"As far as potency goes, it's been surprising how strong a lot of the marijuana is," LaFrate says. "We've seen potency values close to 30 percent THC, which is huge." LaFrate is the president and director of research of Charas Scientific, one of eight labs certified by Colorado to do potency testing.

THC is an abbreviation for tetrahydrocannabinol, which is the psychoactive compound in the plant. He explains that three decades ago, THC levels were well below 10 percent. Its content has tripled in some strains because producers have been cross-breeding them over the years to meet user demands for higher potency, he says.

But an unexpected consequence of this breeding has occurred, says LaFrate. Many of the samples his lab has tested have little to no cannabidiol, or CBD. CBD is a lesser known compound in marijuana that is of increasing interest to medical marijuana proponents. Researchers are investigating CBD as a treatment for schizophrenia, Huntington's disease, and Alzheimer's disease. It is also being considered for anxiety and depression. But unlike THC, CBD doesn't get people high -- that's a key trait for many people who are wary of buzz-inducing drugs and for potential medical treatments for children. As for recreational users, the lack of CBD in marijuana means that many of the hundreds of strains they select from could in actuality be very similar chemically, according to LaFrate.

"There's a lot of homogeneity whether you're talking medical or retail level," he says. "One plant might have green leaves and another purple, and the absolute amount of cannabinoids might change, which relates to strength. But the ratio of THC to CBD to other cannabinoids isn't changing a whole lot." That means there might be little difference in how the varieties make you feel, even though some people claim one kind will make you mellow and another will make you alert, LaFrate explains.

As for contamination testing, although Colorado doesn't yet require it, some producers have voluntarily submitted samples to see what's in their products. LaFrate says the results have been surprising. His lab looks for both biological and chemical contaminants, such as pathogenic microbes and solvents.

"It's pretty startling just how dirty a lot of this stuff is," he says. "You'll see a marijuana bud that looks beautiful. And then we run it through a biological assay, and we see that it's covered in fungi."

The lab also finds varying levels of chemical contaminants such as butane, which is used to create marijuana extracts. Contamination isn't necessarily a cause for alarm, but it does signal a need to figure out what levels are safe.

"It's a natural product," LaFrate says. "There's going to be microbial growth on it no matter what you do. So the questions become: What's a safe threshold? And which contaminants do we need to be concerned about?"

In other words, legalizing marijuana has raised a lot of issues that still have to be hammered out. LaFrate, who has been involved with the policy side of Colorado's new marijuana market, as well as the laboratory side, says he expects regulations will continue to evolve as scientists, lawmakers and others learn more about the plant and its products.

[Source: American Chemical Society]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
FEB 14, 2021
Chemistry & Physics
Enhancing fluorescence signals from biomarkers using nanotechnology
FEB 14, 2021
Enhancing fluorescence signals from biomarkers using nanotechnology
In a new study published in Nature Communications, researchers from Ludwig-Maximilians-Universität München (LM ...
MAR 04, 2021
Chemistry & Physics
The magic vibrational powers of frog lungs
MAR 04, 2021
The magic vibrational powers of frog lungs
Ever tried picking someone up at a loud, crowded bar? It’s not easy – not only may they not hear your fabulo ...
MAR 09, 2021
Chemistry & Physics
Cobalt-free cathode paves the way for new developments in EV batteries
MAR 09, 2021
Cobalt-free cathode paves the way for new developments in EV batteries
A new development in the advancement of the electric vehicle (EV) industry has been described by Professor Byoungwoo Kan ...
MAY 17, 2021
Chemistry & Physics
Recycling: can we do it better?
MAY 17, 2021
Recycling: can we do it better?
Do you consider yourself an environmentally conscious citizen? You recycle, right? Maybe even compost? But did you know ...
MAY 21, 2021
Space & Astronomy
Alien Radioactive Element Discovered on Earth for First Time
MAY 21, 2021
Alien Radioactive Element Discovered on Earth for First Time
  Researchers from Australian National University have discovered the first ever extraterrestrial radioactive isoto ...
JUN 13, 2021
Chemistry & Physics
How to 3D print customizable artificial body parts and medical devices
JUN 13, 2021
How to 3D print customizable artificial body parts and medical devices
Researchers from the University of Nottingham have figured out a new 3D printing process technique that allows for the m ...
Loading Comments...